Search results for "circulatory and respiratory physiology"

showing 10 items of 329 documents

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial …

2012

The inhaled corticosteroid fluticasone propionate (fluticasone) and the long-acting β₂ agonist formoterol fumarate (formoterol) have been combined in a single aerosol inhaler fluticasone/formoterol (flutiform(®)). This study compared the efficacy and safety of fluticasone/formoterol with the combination product budesonide/formoterol (Symbicort(®) Turbohaler(®)).A randomized, double-blind, double-dummy, multicenter, Phase 3 study comprising a 7- (± 3) day screening, 2-4-week run-in, and 12-week treatment periods. Patients aged ≥ 12 years with moderate to severe persistent asthma for ≥ 6 months before screening and forced expiratory volume in one second (FEV₁) 50-80% predicted and ≥ 15% rever…

Pulmonary and Respiratory MedicineBudesonideAdultMaleAdolescentFluticasone propionateYoung AdultDouble-Blind Methodimmune system diseasesForced Expiratory VolumeFormoterol FumarateAdministration InhalationImmunology and AllergyMedicineHumansBudesonideFluticasoneAgedbusiness.industryInhalerDry Powder Inhalersrespiratory systemMiddle AgedAsthmarespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsBudesonide/formoterolEthanolaminesAnesthesiaPediatrics Perinatology and Child HealthSalbutamolFluticasoneFormoterol FumarateFemaleFormoterolbusinesshormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.

2020

AIMS There is conflicting evidence on whether in treated hypertensive patients the risk of renal outcomes is associated with visit-to-visit SBP variability. Furthermore, limited evidence is available on how important is SBP variability for prediction of renal outcomes compared with on-treatment mean SBP. We addressed these issues in 28 790 participants of the Ongoing Treatment Alone and in combination with Ramipril Global End point Trial and Telmisartan Randomized Assessment Study in ace iNtolerant Subjects with Cardiovascular Disease trials. METHODS AND RESULTS SBP variability was expressed as the coefficient of variation of the mean with which it showed no relationship. SBP variability an…

Ramiprilmedicine.medical_specialtyPhysiologyBlood Pressure030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineInternal MedicineMedicineHumanscardiovascular diseases030212 general & internal medicineAntihypertensive AgentsCreatininebusiness.industryIncidence (epidemiology)Confoundingmedicine.diseaseBlood pressureMean blood pressurechemistryCreatinineHypertensionCardiologyKidney Failure ChronicMicroalbuminuriaTelmisartanCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiologymedicine.drugJournal of hypertension
researchProduct

Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfu…

2015

Objective Conflicting evidence exists on the benefits of treating patients with coronary artery disease and preserved left ventricular ejection fraction (LVEF) with an ACE inhibitor. This retrospective analysis of the SMILE-4 Study sought to compare the efficacy of zofenopril 60 mg plus acetylsalicylic acid (ASA) versus ramipril 10 mg plus ASA 100 mg in patients with acute myocardial infarction (AMI) and heart failure, according to an impaired or preserved LVEF. Methods The primary study end point was 1-year combined occurrence of death or hospitalisation for cardiovascular causes. A preserved LVEF was defined by a baseline LVEF >40% and an impaired one by an LVEF ≤40%. Results 448 patients…

Ramiprilmedicine.medical_specialtyacute myocardial infarctionInfarctionramiprilCoronary Artery DiseaseCoronary artery diseasechemistry.chemical_compoundInternal medicinemedicinezofenopril1506cardiovascular diseasesMyocardial infarctionleft ventricular dysfunctionEjection fractionbusiness.industryleft ventricular ejection fractionmedicine.diseaseZofenoprilangiotensin-converting enzyme inhibitorsangiotensin-converting enzyme inhibitorchemistryacute myocardial infarction; angiotensin-converting enzyme inhibitors; left ventricular dysfunction; left ventricular ejection fractionHeart failureACE inhibitorcardiovascular systemCardiologyCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiologyBiomedical engineeringmedicine.drugOpen Heart
researchProduct

"Table 3" of "Studies of W boson plus jets production in p\bar{p} collisions at sqrt(s)=1.96 TeV"

2013

Differential production cross-section, normalized to the measured inclusive W boson cross-section, as a function of third jet rapidity for events with three or more jets produced in association with a W boson. First uncertainty is statistical, second uncertainty is systematic.

Rapidity DependenceDSIG/DYRAPJet Productionrespiratory systemequipment and suppliescomplex mixturesInclusiveSingle Differential Cross SectionPBAR P --> W+ JETS XPBAR P --> W- JETS X1960.0human activitiesW Productioncirculatory and respiratory physiology
researchProduct

Unveiling gene expression regulation of the Bacillus thuringiensis Cry3Aa toxin receptor ADAM10 by the potato dietary miR171c in Colorado potato beet…

2021

Background The Colorado potato beetle (CPB) is a worldwide devastating pest of potato plants and other Solanaceae characterized by its remarkable ability to evolve resistance to insecticides. Bacillus thuringiensis (Bt) Cry3Aa toxin represents an environmentally-safe alternative for CPB control but larvae susceptibility to this toxin has been reported to vary depending on the host plant on which larvae feed. To gain more insight into how nutrition mediates Bt tolerance through effects on gene expression here we explored the post-transcriptional regulation by miRNAs of the CPB-ADAM10 gene encoding the Cry3Aa toxin functional receptor ADAM10. Results The lower CPB-ADAM10 gene expression in CP…

Regulation of gene expressionbiologyToxinfungiColorado potato beetlefood and beveragesGeneral Medicinebiology.organism_classificationmedicine.disease_causeMicrobiologysurgical procedures operativeInsect ScienceBacillus thuringiensisGene expressionmedicinePEST analysisAgronomy and Crop ScienceGeneSolanaceaecirculatory and respiratory physiologyPest Management Science
researchProduct

Atrial Natriuretic Peptide presence in parotid gland of human fetus at 13th week of development and in adult man

2013

Our immunohistochemical study shows that atrial natriuretic peptide (ANP) is present in both human fetal and adult parotid gland. In the fetuses ANP is localized in cell clusters, while in adult parotid gland, the ANP is seen only in the wall of intra- and extralobular ducts. The results suggest that ANP might play a role in the differentiation of the parotid gland similarly as in brain and that during fetal growth ANP may play a role in the regulating the secretion of primitive salivary fluid, even if acini are still not developed. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 1, 55-58)

Settore BIO/17 - IstologiaAdultMalemedicine.medical_specialtyHistologyGestational AgePeptide hormonePathology and Forensic MedicineFetusstomatognathic systemAtrial natriuretic peptideANPhuman parotid glandontogenyInternal medicineinglesemedicineAcinar cellHumansParotid GlandSecretionFetusSettore BIO/16 - Anatomia Umanabusiness.industryGeneral MedicineParotid glandmedicine.anatomical_structureEndocrinologyHuman fetalcardiovascular systemImmunohistochemistrybusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyFolia Histochemica et Cytobiologica
researchProduct

Subclinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population.

2016

Lung function impairment has previously been related to heart failure, although no overt cardiovascular or structural heart disease is present. The extent to which pulmonary function is related to subclinical left ventricular impairment in the general population remains to be investigated.15010 individuals from the general population (mean age 55±11years, 50.5% men) in the Gutenberg Health Study underwent spirometry, transthoracic echocardiography and biomarker measurement. Forced expiratory volume in 1s (FEV1) and forced vital capacity (FVC) in percent of the predicted value and FEV1/FVC ratio were associated with echocardiographic measures of cardiac structure, systolic and diastolic func…

SpirometryAdultMalemedicine.medical_specialtyCardiac outputHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyPulmonary function testing03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineRisk FactorsInternal medicineForced Expiratory VolumemedicineHumansProspective StudiesLungAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryStroke Volumerespiratory systemMiddle Agedmedicine.diseaserespiratory tract diseases030228 respiratory systemHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractioncirculatory and respiratory physiologyInternational journal of cardiology
researchProduct

Prognostic value of FEV1/FEV6 in elderly people*

2010

Summary Background:  The ratio of forced expiratory volume in 1 s and forced expiratory volume in 6 s (FEV1/FEV6) has been proposed as an alternative for FEV1/forced vital capacity (FVC) to diagnose obstructive diseases with less effort during spirometry; however, its prognostic value is unknown. We evaluated whether FEV1/FEV6 is a significant predictor of mortality in elderly subjects and compared its prognostic value with that of FEV1/FVC and FEV1. Methods:  One thousand nine hundred and seventy-one subjects, aged >65 years, participated in the population-based SA.R.A. study. During the baseline exam, a multidimensional assessment included spirometry. Vital status was determined during 6 …

SpirometryVital capacitymedicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testPhysiologybusiness.industryMortality rateHazard ratioPopulationGeneral Medicinerespiratory systemrespiratory tract diseasesFEV1/FVC ratioPhysiology (medical)Internal medicinePredictive value of testsmedicinePhysical therapyeducationbusinessSurvival ratecirculatory and respiratory physiologyClinical Physiology and Functional Imaging
researchProduct

Suppressive effects of C3b on monocyte-dependent T cell proliferation.

1987

The effect of C3b treatment of human monocytes on secondary antigen-dependent T cell response was studied. When antigen-specific T cell blasts were cultivated together with C3b-treated monocytes the proliferative response was inhibited in a dose-dependent fashion. This suppressive effect was specific for C3b because heat-inactivated C3b or buffer alone had no influence on T cell proliferation. In part, this suppressive effect is mediated through a C3b-induced decreased expression of class II antigens on the surface of treated monocytes, but another suppressive mechanism exists because the C3b pretreatment of monocytes also led to an inhibition of the proliferative response in a class II ant…

T cellT-LymphocytesImmunologyIndomethacinchemical and pharmacologic phenomenaBiologyIn Vitro TechniquesInhibitory postsynaptic potentialT cell responseLymphocyte ActivationMonocytesmedicineImmune ToleranceImmunology and AllergyHumansCells CulturedMonocyteComplement C3Molecular biologyProliferative responsemedicine.anatomical_structureComplement C3dComplement C3bImmunologic MemoryClass II Antigenscirculatory and respiratory physiologyEuropean journal of immunology
researchProduct

Cultured Ito cells of rat liver express the alpha 2-macroglobulin gene.

1987

Ito cells were isolated from rat liver and kept in culture for up to 13 days. The capability of the Ito cells to synthesize a2-macroglobulin was analyzed at different times after isolation and by pulse-chase experiments. Newly synthesized a2-macroglobulin was determined by immunoprecipitation followed by sodium dodecyl sulfate/ polyacrylamide gel electrophoresis and fluorography. a2-Macroglobulin synthesis was hardly detectable in Ito cells and their media 3 days after plating. However, 5 - 11 days after the isolation of the cells, increasing amounts of a2-macroglobulin were synthesized. The results of pulse-chase experiments performed on day 7 showed that radioactively labeled a2-macroglob…

Time FactorsBiologydigestive systemBiochemistrychemistry.chemical_compoundfluids and secretionsAnimalsalpha-MacroglobulinsNorthern blotRNA MessengerSodium dodecyl sulfatePancreatic elastasePolyacrylamide gel electrophoresisCells CulturedImmunoassayDNALipid MetabolismMolecular biologyMacroglobulinRatsSecretory proteinPerisinusoidal spaceBiochemistrychemistryGene Expression RegulationLiverHepatic stellate cellElectrophoresis Polyacrylamide GelFemalecirculatory and respiratory physiologyEuropean journal of biochemistry
researchProduct